InsidersTradesSigma
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
Explore the full record of transactions filed by Victoria Hull. Officer active across 1 company, notably Hikma Pharmaceuticals PLC. In total, 3 filings have been published. Activity tracked since 8 April 2025. The latest transaction was filed on 27 April 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条